Drugs / Vero cell-drived inactive Japanese encephalitis vaccine
Vero cell-drived inactive Japanese encephalitis vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06331702 | Mar 2024 → Feb 2025 | Japanese encephalitis, measles, mumps infectious disease, rubella | Liaoning Chengda Biotechnology CO., LTD | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vero cell-drived inactive Japanese encephalitis vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06331702 ↗ |
| Modality | Vaccine | “Japanese encephalitis vaccine” NCT06331702 ↗ |
| Route | Intramuscular | “by intramuscular injection” NCT06331702 ↗ |